| Relation between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Presence and Severity of Erectile Dysfunction |
5 |
| The recommendations of the S2k guideline for the diagnosis, therapy and metaphylaxis of urolithiasis provide a safe course of action for ureterorenoscopic stone treatment - results of the BUSTER study |
2 |
| The ISAR-positive patient in urology |
2 |
| Comparison of Different Treatment Schedules of Mitomycin C Intravesical Instillation in High-Risk Superficial Bladder Cancer Patients |
2 |
| The significance of palliative surgery in castration-resistant prostate cancer |
2 |
| Current recommendations for the systemic treatment of metastatic renal cell carcinoma |
2 |
| 50 years of minimally invasive surgery in Urology |
2 |
| Combined treatment of endometriosis: radical yet gentle |
2 |
| Management of penile cancer patients: new aspects of a rare tumour entity |
2 |
| Surgical management of female stress urinary incontinence |
1 |
| Diagnostic and therapeutic concepts for vesicovaginal and ureterovaginal fistulas |
1 |
| Female stress incontinence: aspects of pathogenesis and functional anatomy |
1 |
| Abiraterone plus prednisone in patients with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer (mHSPC) |
1 |
| Status quo 5 years after the introduction of the new ISUP 2014/WHO 2016 prostate cancer grade groups |
1 |
| The significance of psycho-oncology for urology |
1 |
| Online support groups for patients with prostate cancer |
1 |
| Surgical treatment of bladder cancer: advances made in the past 50 years |
1 |
| Legal limits of (online) marketing for doctors |
1 |
| Nocturia in men with benign prostatic hyperplasia |
1 |
| Pharmacological treatment of BPS |
1 |
| Female urology: review of the development in the past 5 decades |
1 |
| Pressure study of two miniaturised amplatz sheaths of 9.5 F and 12 F outer diameter for minimal invasive percutaneous nephrolithotomy (MIP): An ex vivo organ model measurement |
1 |
| Current trends in flexible ureteroscopy: an update |
1 |
| Enhanced endoscopic imaging for urothelial cancer |
1 |
| Augmented reality and virtual reality in the operating theatre status quo und quo vadis |
1 |
| Uro mHealth: health apps in urology |
1 |
| Genetic profiling in the diagnosis of hereditary prostate cancer: Where dowe stand? |
1 |
| Immunotherapy for renal cell carcinoma - current status |
1 |
| Spinal cord injury with neurogenic lower urinary tract dysfunction as a potential risk factor for bladder carcinoma |
1 |
| Symptomatic urinary obstruction in patients with metastatic malignancies |
1 |
| Thermochemotherapy with Mitomycin C: an update on alternative treatment strategies in non- muscleinvasive bladder cancer |
1 |
| The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas |
0 |
| Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma |
0 |
| Radical prostatectomy through the years |
0 |
| Urinary incontinence in geriatric patients: behavioral therapy, toilet training and physiotherapy |
0 |
| Personalised medicine in renal cell tumours |
0 |
| Personalised medicine in urothelial bladder cancer |
0 |
| Role of p16(INK4A) in detection of human papillomavirus DNA and stratification of cancer-specific mortality on the basis of long term follow-up data of 34 patients with invasive penile cancer |
0 |
| Personalised medicine in prostate cancer |
0 |
| Mixed epithelial and stromal tumour of the kidney: a case report |
0 |
| Severe thoracic bleeding-25 years after nephrectomy |
0 |
| Palliative surgery for metastatic urothelial cancer |
0 |
| Symptomatic renal tumours in metastatic renal cell carcinoma - surgical options |
0 |
| Urethral sarcoma 14 years after brachytherapy of the prostate gland |
0 |
| Reflexions on 50 Years of Sexual Medicine in Urology Focusing on Male Sexual Dysfunctions |
0 |
| Long-term follow up of the serosa-lined and tapered Ileum as an efferent segment of various urinary diversion reservoirs ('Fulda-nipple) |
0 |
| Intra- and postoperative complications classified according to the Clavien-Dindo classification in patients > 80 years after transurethral resection of the urinary bladder |
0 |
| Immune checkpoint inhibition in metastatic urothelial carcinoma |
0 |
| The Rezum system in the treatment of male lower urinary tract symptoms (LUTSs) due to benign prostatic obstruction (BPO) |
0 |
| High-throughput molecular analysis of urothelial carcinoma: potential clinical applications |
0 |
